Pretreatment of infant formula with sodium polystyrene sulfonate: Focus on optimal amount and contact time

Pediatric Drugs

Volumn 15, Issue 1, 2013, Pages 43-48

  Cameron, Jean Christy F ^a,b   Kennedy, Dana ^b   Feber, Janusz ^b   Wong, Elaine ^b   Geier, Pavel ^b   Vaillancourt, Régis ^b  

^a UNIVERSITY OF WATERLOO   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

POLYSTYRENESULFONATE SODIUM; POTASSIUM; SODIUM;

ADD ON THERAPY; ARTICLE; ARTIFICIAL MILK; CAREGIVER; CLINICAL EFFECTIVENESS; CONCENTRATION (PARAMETERS); HOME; HUMAN; HYPERKALEMIA; PARENT; PREMEDICATION; PRIORITY JOURNAL; SAMPLE;

HUMANS; HYPERKALEMIA; INFANT; INFANT FORMULA; POLYSTYRENES; POTASSIUM; POTASSIUM, DIETARY; SODIUM; TIME FACTORS;

EID: 84873395491     PISSN: 11745878     EISSN: 11792019     Source Type: Journal    
DOI: 10.1007/s40272-012-0003-3     Document Type: Article

References (13)

1. Krenitsky J. Nutrition in renal failure: myths and management. Practical Gastroenterology. 2004;XXVIII(9):40-59.
2. Kayexalate drug monograph. Laval: Sanofi-Aventis Canada Inc., 2006.
3. Abraham SC, Bhagavan BS, Lee LA, et al. Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings. Am J Surg Pathol. 2001;25:637-44.
4. Chatelain D, Brevet M, Manaouil D, et al. Rectal stenosis caused by foreign body reaction to sodium polystyrene sulfonate crystals (Kayexalate). Ann Diagn Pathol. 2007;11:217-9.
5. Gonzalez-Cuyar LF, Cresswell NB, Burke AP. Sodium polystyrene sulfonate (Kayexalate) aspiration. Diagn Pathol. 2008;3:27.
6. Rogers FB, Li SC. Acute colonic necrosis associated with sodium polystyrene sulfonate (Kayexalate) enemas in a critically ill patient: case report and review of the literature. J Trauma. 2001;51:395-7.
7. Ziessman HA. Alkalosis and seizure due to a cation: exchange resin and magnesium hydroxide. South Med J. 1976;69:497-9.
8. Bonnet L, Goudable J, Accominotti M, et al. Effect of ion exchange resins on the composition of milk [in French]. Nephrologie. 1997;18:287-9.
9. Bunchman TE, Wood EG, Schenck MH, et al. Pretreatment of formula with sodium polystyrene sulfonate to reduce dietary potassium intake. Pediatr Nephrol. 1991;5:29-32.
10. Fassinger N, Dabbagh S, Mukhopadhyay S, et al. Mineral content of infant formula after treatment with sodium polystyrene sulfonate or calcium polystyrene sulfonate. Adv Perit Dial. 1998;14:274-7.
11. Rivard AL, Raup SM, Beilman GJ. Sodium polystyrene sulfonate used to reduce the potassium content of a high-protein enteral formula: a quantitative analysis. JPEN J Parenter Enteral Nutr. 2004;28:76-8.
12. Schroder CH, van den Berg AM, Willems JL, et al. Reduction of potassium in drinks by pre-treatment with calcium polystyrene sulphonate. Eur J Pediatr. 1993;152:263-4.
13. Hobbs DJ, Gast TR, Ferguson KB, et al. Nutrition management of hyperkalemic infants with chronic kidney disease using adult renal formulas. J Ren Nutr. 2010;20:121-6.